Company Information

PHARMAIDS PHARMACEUTICALS LTD.

NSE : NABSE : 524572ISIN CODE : INE117D01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE59.78-1.21 (-1.98 %)
PREV CLOSE ( ) 60.99
OPEN PRICE ( ) 60.99
BID PRICE (QTY) 59.78 (300)
OFFER PRICE (QTY) 59.78 (17153)
VOLUME 4950
TODAY'S LOW / HIGH ( )59.78 60.99
52 WK LOW / HIGH ( ) 27.6679.23
NSE
This Company is not listed in NSE
ChairmanShankarappa Nagaraja Vinaya Babu
Company SecretaryKaushik Kumar
Non Executive Independent DirectorMopperthy Sudheer
P N Vijay
Methuku Nagesh
Whole Time DirectorVenu Madhava Kaparthy
Mini Manikantan
Non Independent & Non Executive DirectorShreedhara Shetty
Incorporation Year : 01-03 1989

Registered Office :

Address : Unit 201, 2nd Floor, Brigade Rubix,20/14, H M T Factory Main Road,Peenya Plantation Bengaluru,
Karnataka-560013 .

Phone : 080- 49784319

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.